Baidu
map
筛选条件 共查询到104条结果
排序方式
Lung cancer organoids, a promising model still with long way to go

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 171 ()

Lung cancer organoids (LCOs) have sprung up in more and more researching fields, because of their ability to recapitulate the three-dimensional struct......

JIF:6.057

Effectiveness of different treatment strategies in elderly patients with glioblastoma: An evidence map of randomized controlled trials

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 173 ()

To summarize randomized controlled trials (RCTs) evidence for the effectiveness of available treatment strategies for elderly patients with glioblasto......

JIF:6.057

Real-world insights into the efficacy and safety of tyrosine kinase inhibitors against thyroid cancers

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 172 ()

Based on clinical trials demonstrating favorable short-term efficacy and tolerable toxicity, several tyrosine kinase inhibitors have been approved for......

JIF:6.057

Significance of HOXD transcription factors family in progression, migration and angiogenesis of cancer

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 179 ()

The transcription factors (TFs) of the HOX family play significant roles during early embryonic development and cellular processes. They also play a k......

JIF:6.057

Molecular mechanisms of ferroptosis and its role in prostate cancer therapy

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 176 ()

Prostate cancer (PCa) is a highly prevalent disease that affects men's health worldwide and is the second most common malignancy in males. Ferroptosis......

JIF:6.057

Circulating tumor DNA-minimal residual disease: An up-and-coming nova in resectable non-small-cell lung cancer

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 179 ()

Circulating tumor DNA (ctDNA) in the bloodstream can be used to reliably identify a minimal residual disease (MRD). ctDNA-MRD has demonstrated clinica......

JIF:6.057

Prediction performance of twelve tumor mutation burden panels in melanoma and non-small cell lung cancer

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()

As a potential biomarker to predict the response to immunotherapy, tumor mutation burden (TMB) which can be estimated by the cancer gene panel (CGP) h......

JIF:6.057

Roles of fusion genes in digestive system cancers: Dawn for cancer precision therapy

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 171 ()

For advanced cancers of the digestive system, personalized, precise treatment can be life saving. With the development of next-generation sequencing t......

JIF:6.057

Donor-derived and off-the-shelf allogeneic anti-CD19 CAR T-cell therapy for R/R ALL and NHL: A systematic review and meta-analysis

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 179 ()

Allogeneic anti-CD19 chimeric antigen receptor (CAR) T-cell therapy has the potential for extensive clinical applications. This study aimed to evaluat......

JIF:6.057

Prognostic potential of circulating tumor DNA detection at different time periods in resectable non-small cell lung cancer: Evidence from a meta-analysis

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 177 ()

This study was undertaken to evaluate the prognostic significance of circulating tumour DNA (ctDNA) detection at different time periods in resectable ......

JIF:6.057

The role of autophagy in initiation, progression, TME modification, diagnosis, and treatment of esophageal cancers

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 175 ()

Autophagy is a highly conserved metabolic process with a cytoprotective function. Autophagy is involved in cancer, infection, immunity, and inflammati......

JIF:6.057

Pseudoprogression in lung cancer patients treated with immunotherapy

期刊: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()

Lung cancer has attracted much attention because of its high morbidity and mortality worldwide. The advent of immunotherapy approaches, especially the......

JIF:6.057

共104条页码: 1/7页15条/页
Baidu
map
Baidu
map
Baidu
map